Filing Details
- Accession Number:
- 0001237899-12-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-16 15:38:44
- Reporting Period:
- 2012-02-14
- Filing Date:
- 2012-02-16
- Accepted Time:
- 2012-02-16 15:38:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1403178 | S Douglas Mccorkle | 777 Old Saw Mill River Road Tarrytown NY 10591 | Vp Controller And Asst Treasur | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-02-14 | 500 | $21.92 | 500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-14 | 500 | $110.50 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-02-14 | 4,062 | $21.92 | 4,062 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-14 | 4,062 | $109.01 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-02-14 | 15,438 | $21.92 | 15,438 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-14 | 3,048 | $111.01 | 12,390 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-02-14 | 4,807 | $111.01 | 7,583 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2012-02-14 | 15,000 | $16.80 | 22,583 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-14 | 2,269 | $111.01 | 20,314 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-02-14 | 5,864 | $111.01 | 14,450 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-02-15 | 9,097 | $111.08 | 5,353 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-16 | 5,353 | $107.50 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-02-14 | 500 | $0.00 | 500 | $21.92 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-02-14 | 4,062 | $0.00 | 4,062 | $21.92 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-14 | 15,000 | $0.00 | 15,000 | $16.80 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-14 | 15,438 | $0.00 | 15,438 | $21.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,062 | 2017-12-17 | No | 4 | M | Direct | |
0 | 2017-12-17 | No | 4 | M | Direct | |
0 | 2018-12-17 | No | 4 | M | Direct | |
0 | 2017-12-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,264 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 9,097 shares of Company stock on February 15, 2012 at prices ranging from $111.00 to $111.38 . Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2012 at each separate price.
- Represents volume-weighted average price of sales of 5,353 shares of Company stock on February 16, 2012 at prices ranging from $107.50 to $107.51 . Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 16, 2012 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.